Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Birrer

Showing results (91-100 of 222) with videos related to

Pageof 23
Sort By:
Molecular Cancer Research : MCR|September 12, 2012
SUZ12 promotes human epithelial ovarian cancer by suppressing apoptosis via silencing HRKHua Li, Qi Cai, Hong Wu, et al.
Plos One|June 3, 2016
CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer PrognosisAmanda Sosulski, Heiko Horn, Lihua Zhang, et al.
Cancer Research|July 3, 2008
A gene signature predicting for survival in suboptimally debulked patients with ovarian cancerTomas Bonome, Douglas A Levine, Joanna Shih, et al.
Gynecologic Oncology|March 11, 2009
Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: a Gynecologic Oncology Group StudyJohn Farley, Sartoru Fuchiuji, Kathleen M Darcy, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2013
Ascites analysis by a microfluidic chip allows tumor-cell profilingVanessa M Peterson, Cesar M Castro, Jaehoon Chung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2016
Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion StudyKathleen N Moore, Lainie P Martin, David M O'Malley, et al.
BMC Bioinformatics|August 5, 2022
DAGBagM: learning directed acyclic graphs of mixed variables with an application to identify protein biomarkers for treatment response in ovarian cancerShrabanti Chowdhury, Ru Wang, Qing Yu, et al.
Database : the Journal of Biological Databases and Curation|April 4, 2013
curatedOvarianData: clinically annotated data for the ovarian cancer transcriptomeBenjamin Frederick Ganzfried, Markus Riester, Benjamin Haibe-Kains, et al.
Journal of the National Cancer Institute|March 15, 2014
Better therapeutic trials in ovarian cancerMichael A Bookman, C Blake Gilks, Elise C Kohn, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2015
AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancerDavid Pépin, Amanda Sosulski, Lihua Zhang, et al.
Pageof 23

Showing results (91-100 of 222) with videos related to

Sort By:
Pageof 23
Molecular Cancer Research : MCR|September 12, 2012
SUZ12 promotes human epithelial ovarian cancer by suppressing apoptosis via silencing HRKHua Li, Qi Cai, Hong Wu, et al.
Plos One|June 3, 2016
CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer PrognosisAmanda Sosulski, Heiko Horn, Lihua Zhang, et al.
Cancer Research|July 3, 2008
A gene signature predicting for survival in suboptimally debulked patients with ovarian cancerTomas Bonome, Douglas A Levine, Joanna Shih, et al.
Gynecologic Oncology|March 11, 2009
Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: a Gynecologic Oncology Group StudyJohn Farley, Sartoru Fuchiuji, Kathleen M Darcy, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2013
Ascites analysis by a microfluidic chip allows tumor-cell profilingVanessa M Peterson, Cesar M Castro, Jaehoon Chung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2016
Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion StudyKathleen N Moore, Lainie P Martin, David M O'Malley, et al.
BMC Bioinformatics|August 5, 2022
DAGBagM: learning directed acyclic graphs of mixed variables with an application to identify protein biomarkers for treatment response in ovarian cancerShrabanti Chowdhury, Ru Wang, Qing Yu, et al.
Database : the Journal of Biological Databases and Curation|April 4, 2013
curatedOvarianData: clinically annotated data for the ovarian cancer transcriptomeBenjamin Frederick Ganzfried, Markus Riester, Benjamin Haibe-Kains, et al.
Journal of the National Cancer Institute|March 15, 2014
Better therapeutic trials in ovarian cancerMichael A Bookman, C Blake Gilks, Elise C Kohn, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2015
AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancerDavid Pépin, Amanda Sosulski, Lihua Zhang, et al.
Pageof 23